Advertisement
News
Advertisement

J&J Accepts $4B Carlyle Offer for Diagnostics Unit

Mon, 03/31/2014 - 8:04am

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson says it has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.

J&J says the deal for the blood-testing unit should close by mid-year. Its shares rose in premarket trading.

The New Brunswick, N.J., health care giant said in January that Washington, D.C.-based Carlyle Group had offered $4.15 billion for the business, and that it would talk to works councils and trade unions representing its employees before making a decision.

The Ortho-Clinical business serves hospitals, testing laboratories and blood banks. It supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases.

It also makes technology for advanced testing of blood to diagnose health conditions and to monitor medication effects.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading